Understanding Hemophilia

Learn about hemophilia and other bleeding disorders, their causes, and treatments.

Hemophilia and Its Types

Hemophilia is a rare genetic disorder that impairs blood clotting, leading to prolonged bleeding. It's caused by mutations in genes coding for clotting factors, affecting mostly males.

  • Hemophilia A: Hemophilia A is the most common type, accounting for approximately 80% of cases. It's caused by a deficiency or mutation in the factor VIII (FVIII) gene, leading to prolonged bleeding, frequent nosebleeds, and joint pain.
  • Hemophilia B: Hemophilia B is less common, accounting for approximately 20% of cases. It's caused by a deficiency or mutation in the factor IX (FIX) gene, leading to similar symptoms as Hemophilia A, including prolonged bleeding and joint pain.
Hemophilia types
Factor VIII

Factor VIII

Factor VIII (FVIII) is a protein essential for blood clotting, accelerating the activation of factor X to form thrombin, which transforms fibrinogen into fibrin, creating a blood clot. A deficiency or mutation in the FVIII gene leads to Hemophilia A, characterized by prolonged bleeding and increased risk of bleeding complications. Replacement therapy involves injecting recombinant or plasma-derived FVIII into the bloodstream to replace the missing or defective protein, restoring normal blood clotting and preventing bleeding episodes.

Factor IX

Factor IX (FIX) is a protein crucial for blood clotting, working in conjunction with factor VIII to activate factor X, which ultimately forms a blood clot. A deficiency or mutation in the FIX gene causes Hemophilia B (Christmas Disease), characterized by prolonged bleeding and increased risk of bleeding complications. Replacement therapy involves injecting recombinant or plasma-derived FIX into the bloodstream to replace the missing or defective protein, restoring normal blood clotting and preventing bleeding episodes.

Factor IX
VWD Factor

Von Willebrand Disease (VWD)

Von Willebrand Disease (VWD) is a bleeding disorder caused by a deficiency or mutation in the von Willebrand factor (VWF) protein, which plays a crucial role in blood clotting. VWF helps platelets stick together and to the injured blood vessel wall, and also carries factor VIII in the bloodstream. A deficiency or abnormality in VWF leads to VWD, characterized by easy bruising, frequent nosebleeds, and prolonged bleeding after injury or surgery. Treatment options include replacement therapy with VWF concentrates, desmopressin to stimulate VWF release, and medications to promote blood clotting.